Long-Term Efficacy of Adjunctive Cariprazine in Patients With MDD: Results From an Open-Label 26-Week Safety Study

被引：0
|
作者：
Masand, Prakash [1 ]
Vieta, Eduard [1 ]
Waraich, Simranpreet [1 ]
Kramer, Ken [1 ]
Kerolous, Majid [1 ]
机构：
[1] AbbVie, New York, NY USA
来源：
NEUROPSYCHOPHARMACOLOGY | 2023年 / 48卷
关键词：
Cariprazine; Major Depressive Disorder; Depression; Adjunctive; Long-Term;
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
P343
引用
收藏
页码：263 / 264
页数：2
相关论文
共 50 条
  • [31] Long-term safety and effectiveness of berotralstat for hereditary angioedema: The open-label APeX-S study
    Farkas, Henriette
    Stobiecki, Marcin
    Peter, Jonny
    Kinaciyan, Tamar
    Maurer, Marcus
    Aygoren-Pursun, Emel
    Kiani-Alikhan, Sorena
    Wu, Adrian
    Reshef, Avner
    Bygum, Anette
    Fain, Olivier
    Hagin, David
    Huissoon, Aarnoud
    Jesenak, Milos
    Lindsay, Karen
    Panovska, Vesna Grivcheva
    Steiner, Urs C.
    Zubrinich, Celia
    Best, Jessica M.
    Cornpropst, Melanie
    Dix, Daniel
    Dobo, Sylvia M.
    Iocca, Heather A.
    Desai, Bhavisha
    Murray, Sharon C.
    Nagy, Eniko
    Sheridan, William P.
    CLINICAL AND TRANSLATIONAL ALLERGY, 2021, 11 (04)
  • [32] Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: Long-term efficacy and safety results from 2 randomized phase-III studies and 1 open-label long-term extension study
    Papp, Kim A.
    Krueger, James G.
    Feldman, Steven R.
    Langley, Richard G.
    Thaci, Diamant
    Torii, Hideshi
    Tyring, Stephen
    Wolk, Robert
    Gardner, Annie
    Mebus, Charles
    Tan, Huaming
    Luo, Yingchun
    Gupta, Pankaj
    Mallbris, Lotus
    Tatulych, Svitlana
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : 841 - 850
  • [33] An Interim Report of a Phase 3, Long-Term, Open-Label Study to Evaluate Efficacy and Safety of Difamilast Ointment in Japanese Infants with Atopic Dermatitis
    Saeki, Hidehisa
    Ohya, Yukihiro
    Baba, Naoko
    Imamura, Tomomi
    Yokota, Daisuke
    Tsubouchi, Hidetsugu
    DERMATOLOGY AND THERAPY, 2024, 14 (09) : 2443 - 2455
  • [34] Efficacy and safety of secukinumab in Japanese patients with active ankylosing spondylitis: 24-week results from an open-label phase 3 study (MEASURE 2-J)
    Kishimoto, Mitsumasa
    Taniguchi, Atsuo
    Fujishige, Ayako
    Kaneko, Shuhei
    Haemmerle, Sibylle
    Porter, Brian O.
    Kobayashi, Shigeto
    MODERN RHEUMATOLOGY, 2020, 30 (01) : 132 - 140
  • [35] Lurasidone in the long-term treatment of Japanese patients with bipolar I disorder: a 52 week open label study
    Higuchi, Teruhiko
    Kato, Tadafumi
    Miyajima, Mari
    Watabe, Kei
    Masuda, Takahiro
    Hagi, Katsuhiko
    Ishigooka, Jun
    INTERNATIONAL JOURNAL OF BIPOLAR DISORDERS, 2021, 9 (01)
  • [36] Efficacy, safety and tolerability of escitalopram in doses up to 50 mg in Major Depressive Disorder (MDD): an open-label, pilot study
    Alan G Wade
    Gordon M Crawford
    Ann Yellowlees
    BMC Psychiatry, 11
  • [37] Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study
    Rajnish Mago
    Giovanna Forero
    William M. Greenberg
    Carl Gommoll
    Changzheng Chen
    Clinical Drug Investigation, 2013, 33 : 761 - 771
  • [38] Lurasidone in the long-term treatment of patients with bipolar i disorder: responder and remitter status during a 24-week open-label extension study
    Ketter, T.
    Tsai, J.
    Silva, R.
    Kroger, H.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S420 - S421
  • [39] Long-Term Safety and Efficacy of Subcutaneous Methylnaltrexone in Patients with Opioid-Induced Constipation and Chronic Noncancer Pain: A Phase 3, Open-Label Trial
    Webster, Lynn R.
    Michna, Edward
    Khan, Arif
    Israel, Robert J.
    Harper, Joseph R.
    PAIN MEDICINE, 2017, 18 (08) : 1496 - 1504
  • [40] Long-Term, Open-Label, Safety Study of Edivoxetine Monotherapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
    Nery, Emel Serap Monkul
    Bangs, Mark
    Liu, Peng
    Ahl, Jonna
    Perahia, David
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2017, 27 (08) : 700 - 707
12345